Fascinating.
That explains the apparent duplication.
And it keeps patent lawyers busy.
I guess applicants can't ask to be assigned to their favourite examiner.
Is there a benefit in asking two patent lawyers to patent the same invention in case they express the claims differently?
Ann: Zantrene highly effective in Melanoma preclinical study, page-178
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.015(0.90%) |
Mkt cap ! $276.8M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.61 | $156.3K | 95.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4344 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 2731 | 2 |
View Market Depth
| Last trade - 15.49pm 06/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |